Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

A non-exhaustive repository of COVID-19 related scientific publications undertaken by LSHTM researchers since the beginning of the outbreak.

Childhood COVID-19 vaccine acceptance and preference from caregivers and healthcare workers in China: A survey experiment.
Hou, Z; Song, K; Wang, Q; Zang, S; Tu, S; CHANTLER, T; LARSON, HJ;
2022
Preventive medicine, (2022).161, 10.1016/j.ypmed.2022.107138.
SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway.
Willett, BJ; Grove, J; MacLean, OA; Wilkie, C; De Lorenzo, G; Furnon, W; Cantoni, D; Scott, S; Logan, N; Ashraf, S; Manali, M; Szemiel, A; Cowton, V; Vink, E; Harvey, WT; Davis, C; Asamaphan, P; Smollett, K; Tong, L; Orton, R; Hughes, J; Holland, P; Silva, V; Pascall, DJ; Puxty, K; ... Thomson, EC.
2022
Nature Microbiology, (2022).7 8 10.1038/s41564-022-01143-7.
Social and Behavioral Factors Associated with Lack of Intent to Receive COVID-19 Vaccine, Japan.
ARASHIRO, T; Arima, Y; Stucky, A; SMITH, C; HIBBERD, M; Ariyoshi, K; Suzuki, M;
2022
Emerging Infectious Diseases, (2022).28 9 10.3201/eid2809.220300.
The clinical utility and epidemiological impact of self-testing for SARS-CoV-2 using antigen detecting diagnostics: a systematic review and meta-analysis.
Brümmer, L; Erdmann, C; Tolle, H; McGrath, S; OLARU, I; Katzenschlager, S; Yerlikaya, S; Grilli, M; Pollock, N; Erkosar, B; Mace, A; Ongarello, S; JOHNSON, C; Sacks, J; Denkinger, C;
2022
medRxiv (2022). 10.1101/2022.07.03.22277183.
Altered subgenomic RNA abundance provides unique insight into SARS-CoV-2 B.1.1.7/Alpha variant infections.
Parker, MD; Stewart, H; Shehata, OM; Lindsey, BB; Shah, DR; Hsu, S; KEELEY, AJ; Partridge, DG; Leary, S; Cope, A; State, A; Johnson, K; Ali, N; Raghei, R; Heffer, J; Smith, N; Zhang, P; Gallis, M; Louka, SF; Hornsby, HR; Alamri, H; Whiteley, M; Foulkes, BH; Christou, S; Wolverson, P; ... DE SILVA, TI.
2022
Communications biology, (2022).5 1 10.1038/s42003-022-03565-9.
Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: a cohort study from OpenSAFELY.
OpenSAFELY Collaborative,; Green, A; Curtis, H; Hulme, W; WILLIAMSON, E; MCDONALD, H; BHASKARAN, K; RENTSCH, C; SCHULTZE, A; MacKenna, B; MAHALINGASIVAM, V; TOMLINSON, L; Walker, A; Fisher, L; Massey, J; Andrews, C; Hopcroft, L; Morton, C; Croker, R; Morley, J; Mehrkar, A; Bacon, S; Evans, D; Inglesby, P; Hickman, G; ... GOLDACRE, B.
2022
BMC medicine, (2022).20 1 10.1186/s12916-022-02422-0.
Did it hurt? COVID-19 vaccination experience in people with multiple sclerosis.
Allen-Philbey, K; Stennett, A; Begum, T; Johnson, AC; MACDOUGALL, A; Green, S; Dobson, R; Giovannoni, G; Gnanapavan, S; Marta, M; Smets, I; Turner, BP; Baker, D; Mathews, J; Schmierer, K;
2022
Multiple sclerosis and related disorders, (2022).65, 10.1016/j.msard.2022.104022.
Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in Adults in the US.
Goswami, H; Alsumali, A; Jiang, Y; Schindler, M; Duke, ER; Cohen, J; BRIGGS, A; Puenpatom, A;
2022
PharmacoEconomics, (2022).40 7 10.1007/s40273-022-01168-0.
Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform.
Langan, S; McKenna, B; Kennedy, N; Mehkar, A; Rowan, A; Galloway, J; MATTHEWMAN, J; Mansfield, K; Bechman, K; Yates, M; Brown, J; SCHULTZE, A; Norton, S; Walker, A; Morton, C; Harrison, D; BHASKARAN, K; RENTSCH, C; WILLIAMSON, E; Croker, R; Bacon, S; Hickman, G; Ward, T; Davy, S; Green, A; ... Smith, C.
2022
BRITISH JOURNAL OF DERMATOLOGY, (2022).187,
Effectiveness of CoronaVac and BNT162b2 COVID-19 mass vaccination in Colombia: A population-based cohort study.
Paternina-Caicedo, A; JIT, M; Alvis-Guzmán, N; Fernández, JC; Hernández, J; Paz-Wilches, JJ; Rojas-Suarez, J; Dueñas-Castell, C; Alvis-Zakzuk, NJ; Smith, AD; Hoz-Restrepo, FD L;
2022
The Lancet Regional Health Americas, (2022).12, 10.1016/j.lana.2022.100296.